|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 49/04 | (2006.01) |
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3010552 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14731952.9 |
| Date of filing the European patent application | 2014-06-19 | |
| (97) | Date of publication of the European application | 2016-04-27 |
| (45) | Date of publication and mention of the grant of the patent | 2019-04-17 |
| (46) | Date of publication of the claims translation | 2019-07-25 |
| (86) | Number | PCT/EP2014/062976 |
| Date | 2014-06-19 |
| (87) | Number | WO 2014/202738 |
| Date | 2014-12-24 |
| (30) | Number | Date | Country code |
| 13305830 | 2013-06-20 | EP | |
| 201361837406 P | 2013-06-20 | US |
| (72) |
POUL, Laurence, FR
LEVY, Laurent, FR
BERJAUD, Céline, FR
GERMAIN, Matthieu, FR
POTTIER, Agnes, FR
|
| (73) |
Nanobiotix,
60 rue de Wattignies, 75012 Paris,
FR
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Kompozicijos, skirtos naudoti onkologijoje |
| COMPOSITIONS FOR USE IN ONCOLOGY |
| Payment date | Validity (years) | Amount | |
| 2020-06-05 | 7 | 162.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2021-06-19 |